Role of Shear Wave Elastography as Predictor of Immunohistochemistry Profile in Breast Cancer.

Authors

Manali Arora, Vishal Thakker, Kanica Rawat, Devkant Lakhera, Kirti Gupta, Shivani Singh

Published in

Annals of African medicine. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

Breast cancer is a heterogeneous malignancy with varied molecular subtypes having divergent prognosis. Immunohistochemistry (IHC) is the guiding investigation for both prognosis and therapy. IHC although pertinent, still lacks ubiquity thus precluding the need for a readily available modality for assessment of tumor biology. Shear wave elastography (SWE) is a noninvasive ultrasound technique quantifying tissue stiffness, potentially reflecting tumor biology. The present study evaluated the role of SWE in predicting IHC profiles of breast cancers.
A retrospective observational study was conducted over 6 months at a tertiary hospital. Thirty patients with histopathologically proven malignant breast lesions who underwent SWE were included. Elastographic parameters were correlated with IHC markers (estrogen receptor [ER], progesterone receptor [PR], HER2neu, and Ki-67). Statistical analyses included ANOVA, receiver operating characteristic (ROC) curve analysis, and logistic regression using the SPSS software version 30.0.
Mean patient age was 52 ± 10.7 years, with 80% patients presenting with ductal carcinoma. Hormone receptor-positive tumors exhibited significantly higher stiffness than negative ones (E max: P = 0.020 for ER, P = 0.011 for PR). Luminal A and B cancers showed higher E max (81.46 kPa) and E mean (47.33 kPa) than triple-negative breast cancers (TNBC) (E max 54.16 kPa, E mean 35.13 kPa). ROC analysis showed significant diagnostic abilities of SWE for TNBC (area under the curve [AUC] 0.783-0.789) and hormone-positive tumors (AUC 0.757-0.831). However, logistic regression revealed no independent predictive power of SWE parameters for IHC subtyping.
SWE demonstrates distinct stiffness profiles across breast cancer subtypes, with stiffer profiles for hormone receptor-positive tumors than triple-negative ones. While SWE offers adjunctive diagnostic value, it cannot currently replace histopathology for molecular characterization.

PMID:
42798166
Bibliographic data and abstract were imported from PubMed on 26 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.